Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate additional cholesterol lowering effects in
patients with coronary heart disease by giving an investigational drug with a patient's
current approved cholesterol lowering medication.